Neus Basté Rotllan, MD. Medical Oncologist. Head and Neck, Thyroid and Unknown Primary Tumors Unit. Hospital Clinical Barcelona, IDIBAPS. She is the current head of the Head and Neck, Thyroid and Unknow Primary Tumors Oncology Department at Hospital Clinical Barcelona and collaborates with Phase 1 Tumor Unit. Principal investigator of more than 20 clinical trials (Phase I-IV), mainly Head and Neck, Thyroid, Unknown Primary tumors and all solid tumors. She has expertise in translational research in head and neck cancers (HNC) and thyroid carcinomas (TC). She has participated in HNC projects with a focus on immunotherapy (clinical prognostic scores – LIPI, correlation between immune adverse events and patients’ prognosis, predictive biomarkers of response to immunotherapy based on PD-L1 expression) and matched-target therapies. Currently, she is leading the MOLTHY project, an observational, national, multicenter study supported by two cooperative Spanish groups: TTCC and GETNE, which Presidents groups are Ricard Mesia Nin and Jaume Capdevila Castill n, respectively. She is board member of HNCIG and HN EORTC YI group (newsletter and webinars participation) and coordinates the International Relationship of the TTCC group. She is member of other national and international scientific societies (SEOM, TTCC, GETNE, ESMO, EORTC, HNCIG). Coordinator of the MOLTHY project: study design, protocol development, database items, study conduction at all investigators centers with their respective site investigators visits, HCB patient selection, supervision, clinical of accuracy data and tumor sample analyses, interpretation of study results and their presentation to scientific conferences/manuscript.